VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
67 hedge funds and large institutions have $124M invested in Viracta Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 8 closing their positions.
Holders
67
Holders Change
+5
Holders Change %
+8.06%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
19
Reduced
15
Closed
8
Calls
$497K
Puts
$673K
Net Calls
-$176K
Net Calls Change
-$100K
Top Buyers
1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$8.57M |
2 |
ASP
2
Adams Street Partners
Chicago,
Illinois
|
$5.85M |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$4.63M |
4 |
4
Blackstone Inc
New York
|
$1.91M |
5 |
5
State Street
Boston,
Massachusetts
|
$4.63M |